← Back to search

RIGEL PHARMACEUTICALS INC

SOUTH SAN FRANCISCO, CA, 94080

Unclaimed
Small Business

Prime contracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
Office of Assistant Secretary for Preparedness and Response
RIGEL PHARMACEUTICALS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF FOSTAMATINIB TREATMENT DURING HOSPITALIZATION RESULTING FROM ARDS ON LONG-TERM OUTCOMES INCLUDING CLINICAL, BIOMARKER, IMAGING, QOL, FUNCTIONAL AND LUNG FUNCTI—$749,999May 21, 2025May 1, 2023 – Oct 31, 2025

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced
RIGEL PHARMACEUTICALS INC – South San Francisco, CA | UEI X7MHPBCMHFM3 | FedSub